Language Select
Varian Logo

Press Releases

5 月 23, 2018
Varian (NYSE: VAR) today announced that Gary Bischoping, chief financial officer, and J. Michael Bruff, senior vice president of investor relations, will present at the Jefferies Global Healthcare... Read more
5 月 22, 2018
Varian (NYSE: VAR) today announced it received notice from Sirtex Medical Limited (Sirtex) on May 21, 2018 (Pacific daylight time) that the board of directors of Sirtex has now received a binding... Read more
5 月 17, 2018
Varian (NYSE: VAR) today announced it has signed a software technology training and education cooperation agreement with the Brazil Ministry of Health (MOH) and seven universities and science and... Read more
5 月 16, 2018
Varian (NYSE: VAR) announced two patients with brain cancer were the first patients in Korea to be treated using the company's HyperArc™ High Definition Radiotherapy (HDRT), a new type of... Read more
5 月 07, 2018
Varian (NYSE:VAR) today announced it has acquired Cooperative CL Enterprises (COOP), a leading distributor of radiotherapy equipment in Taiwan. COOP currently employs 45 people, and has... Read more
5 月 04, 2018
Varian (NYSE: VAR) today commented on the press release of Sirtex Medical Limited (Sirtex) dated May 4, 2018 announcing that Sirtex had received an unsolicited non-binding, indicative and... Read more
4 月 26, 2018
Varian (NYSE: VAR) today announced Hospital Alemão Oswaldo Cruz in São Paulo, Brazil will be the first hospital in Brazil to install a Halcyon™ treatment system. Scheduled to be installed in... Read more
4 月 25, 2018
Varian (NYSE: VAR) today announced it has signed an agreement with the Stockholm City Council to provide equipment and related services to the radiation therapy department of the New Karolinska... Read more
4 月 25, 2018
Second Quarter 2018 Summary Revenues of $730 million grew 10 percent, or 6 percent in constant currency Oncology gross orders grew 5 percent, or 1 percent in constant currency GAAP operating... Read more
4 月 20, 2018
Varian (NYSE: VAR) today announced it has received FDA 510(k) clearance for its Calypso® Anchored Beacon® transponder. Used with a Varian TrueBeam®, Edge® and Clinac® C-series medical linear... Read more

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
[email protected]

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
[email protected]

Monica Prokocki
Director, Investor Relations
650.424.5184
[email protected]